Atherosclerosis is a lipid-driven chronic inflammatory disease that is modulated by innate and adaptive immunity including humoral immunity. Importantly, antibody alterations achieved by genetic means ...

1 Department of Medical Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia 2 Department of Medical Biochemistry, College of Medicine and Health Sciences, ...

BLOCKING malaria transmission by targeting the malaria parasite inside mosquitoes so that it is no longer transmitted by the mosquito parasites before it can infect humans . A rec ...

Objective To compare acute treatment responses and long-term outcome in leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 patients with LGI1 ...

Adult Swim is no stranger when it comes to housing revivals of Cartoon Network favorites. One of the biggest examples was the fourth and final season of Genndy Tartakovsky’s Samurai Jack.

Two weeks after agreeing to be bought out by Sanofi, Vigil Neuroscience’s monoclonal antibody iluzanebart failed a Phase II study for a rare brain disorder and its development is being discontinued.

BioNTech’s oncology strategy centers on a bispecific antibody that the company envisions as the backbone of many potential drug combinations for many types of cancer. Bristol Myer Squibb is ...

First clinical data presented at ASCO 2025 show a 100% response rate with the trispecific antibody JNJ-5322 among anti-BCMA/-GPTC5D-naïve r/r MM patients. Image ...

Pivekimab sunirine (PVEK), a CD123-targeted antibody-drug conjugate, demonstrated an 85% overall response rate and 70% complete response rate as frontline therapy in newly diagnosed blastic ...

The Food and Drug Administration (FDA) has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody, for the treatment of celiac disease. Celiac disease is ...